Evaluating Omission of Granulocyte Colony-stimulating Factors in Breast Cancer Patients Receiving Paclitaxel Portion of Dose-dense Adriamycin-cyclophosphamide and Paclitaxel Chemotherapy

NCT05753618 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

242

Enrollment

OTHER

Sponsor class

Conditions

Early-stage Breast Cancer

Interventions

DRUG: Granulocyte Colony-Stimulating Factor (G-CSF)
DRUG: Omission of Granulocyte Colony-Stimulating Factor (G-CSF)

Sponsor

Ottawa Hospital Research Institute